Cover Image
Market Research Report

North America Genetic Testing Market (2019-2025)

Published by KBV Research Product code 911079
Published Content info 81 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Genetic Testing Market (2019-2025)
Published: August 31, 2019 Content info: 81 Pages
Description

The North America Genetic Testing Market would witness market growth of 10.6% CAGR during the forecast period (2019-2025).

The incidence of genetic disorders has grown dramatically, which can be caused by several factors, including geographical and environmental changes, significant changes in food habits, pollution, and exposure to risky radiations or chemicals. Genetic testing also serves to evaluate relationships between relatives, including mother, father, half-brother, half-sister, and other people. Forensics and genetic testing have greatly helped the law and order. The overall industry for genetic tests has been expanding and is anticipated to grow rapidly in the near future since more organizations are joining this market.

Diagnostic tests are used to detect or exclude a particular genetic or chromosomal condition. Often genetic testing is used to verify a diagnosis when physical signs and symptoms are suspected of a particular condition. Diagnostic tests may be performed before and at any moment of birth, but not for each gene or genetic condition. Diagnostic test findings can affect a person's health care and disorder management decisions.

Based on Type, the market is segmented into Predictive and Presymptomatic Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Other Types. Based on Technology, the market is segmented into Cytogenetic Testing, Biochemical Testing and Molecular Testing. Based on Application, the market is segmented into Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Myriad Genetics, Inc., Empire Genomics LLC, Bio-Rad Laboratories, Inc., Novartis AG, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Danaher Corporation, and Abbott Laboratories (Abbott Laboratories Molecular, Inc.).

Scope of the Study

Market Segmentation:

By Type

  • Predictive and Presymptomatic Carrier Testing
  • Prenatal and Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Other Types

By Technology

  • Cytogenetic Testing
  • Biochemical Testing and
  • Molecular Testing

By Application

  • Cancer Diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis and
  • Other Applications

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled:

  • Myriad Genetics, Inc.
  • Empire Genomics LLC
  • Bio-Rad Laboratories, Inc.
  • Novartis AG
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Danaher Corporation
  • Abbott Laboratories (Abbott Laboratories Molecular, Inc.)

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Genetic Testing Market, by Type
    • 1.4.2 North America Genetic Testing Market, by Technology
    • 1.4.3 North America Genetic Testing Market, by Application
    • 1.4.4 North America Genetic Testing Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Executive Summary
    • 2.1.3 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. North America Genetic Testing Market by Type

  • 3.1 North America Predictive and Presymptomatic Testing Market by Country
  • 3.2 North America Carrier Testing Market by Country
  • 3.3 North America Prenatal and Newborn Testing Market by Country
  • 3.4 North America Diagnostic Testing Market by Country
  • 3.5 North America Pharmacogenomic Testing Market by Country
  • 3.6 North America Other Types Genetic Testing Market by Country

Chapter 4. North America Genetic Testing Market by Technology

  • 4.1 North America Cytogenetic Testing Market by Country
  • 4.2 North America Biochemical Testing Market by Country
  • 4.3 North America Molecular Testing Market by Country

Chapter 5. North America Genetic Testing Market by Application

  • 5.1 North America Cancer Diagnosis Market by Country
  • 5.2 North America Genetic Disease Diagnosis Market by Country
  • 5.3 North America Cardiovascular Disease Diagnosis Market by Country
  • 5.4 North America Other Applications Market by Country

Chapter 6. North America Genetic Testing Market by Country

  • 6.1 USA Genetic Testing Market
    • 6.1.1 USA Genetic Testing Market by Type
    • 6.1.2 USA Genetic Testing Market by Technology
    • 6.1.3 USA Genetic Testing Market by Application
  • 6.2 Canada Genetic Testing Market
    • 6.2.1 Canada Genetic Testing Market by Type
    • 6.2.2 Canada Genetic Testing Market by Technology
    • 6.2.3 Canada Genetic Testing Market by Application
  • 6.3 Mexico Genetic Testing Market
    • 6.3.1 Mexico Genetic Testing Market by Type
    • 6.3.2 Mexico Genetic Testing Market by Technology
    • 6.3.3 Mexico Genetic Testing Market by Application
  • 6.4 Rest of North America Genetic Testing Market
    • 6.4.1 Rest of North America Genetic Testing Market by Type
    • 6.4.2 Rest of North America Genetic Testing Market by Technology
    • 6.4.3 Rest of North America Genetic Testing Market by Application

Chapter 7. Company Profiles

  • 7.1 Myriad Genetics, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Product Launches:
      • 7.1.5.2 Collaborations, Partnerships and agreements:
  • 7.2 Empire Genomics LLC
    • 7.2.1 Company Overview
  • 7.3 Bio-Rad laboratories, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Recent strategies and developments:
      • 7.3.4.1 Collaborations, partnerships and agreements:
      • 7.3.4.2 Product launches:
      • 7.3.4.3 Acquisition and mergers:
    • 7.3.5 Research & Development Expenses
  • 7.4 Novartis AG
    • 7.4.1 Company Overview
    • 7.4.1 Financial Analysis
    • 7.4.2 Segmental and Regional Analysis
    • 7.4.3 Research & Development Expense
    • 7.4.4 Recent strategies and developments:
      • 7.4.4.1 Collaborations, partnerships and agreements:
  • 7.5 Agilent Technologies, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Product launches:
      • 7.5.5.2 Expansions:
  • 7.6 Thermo Fischer Scientific, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Collaborations, partnerships and agreements:
      • 7.6.5.2 Acquisition and mergers:
  • 7.7 Qiagen N.V.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Product launches:
      • 7.7.5.2 Collaborations, partnerships and agreements:
  • 7.8 Illumina, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Collaborations, partnerships and agreements:
      • 7.8.5.2 Product launches:
  • 7.9 Danaher Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Acquisition and mergers:
  • 7.1 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense
    • 7.10.5 Recent strategies and developments:
      • 7.10.5.1 Collaborations, partnerships and agreements:
      • 7.10.5.2 Product launches:

LIST OF TABLES

  • TABLE 1 NORTH AMERICA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 2 NORTH AMERICA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 3 NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 4 NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 5 NORTH AMERICA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 6 NORTH AMERICA PREDICTIVE AND PRESYMPTOMATIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 7 NORTH AMERICA CARRIER TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 8 NORTH AMERICA CARRIER TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 9 NORTH AMERICA PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 10 NORTH AMERICA PRENATAL AND NEWBORN TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 11 NORTH AMERICA DIAGNOSTIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 12 NORTH AMERICA DIAGNOSTIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 13 NORTH AMERICA PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 14 NORTH AMERICA PHARMACOGENOMIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 15 NORTH AMERICA OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 16 NORTH AMERICA OTHER TYPES GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 17 NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 18 NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 19 NORTH AMERICA CYTOGENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 20 NORTH AMERICA CYTOGENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 21 NORTH AMERICA BIOCHEMICAL TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 22 NORTH AMERICA BIOCHEMICAL TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 23 NORTH AMERICA MOLECULAR TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 24 NORTH AMERICA MOLECULAR TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 25 NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 26 NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 27 NORTH AMERICA CANCER DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 28 NORTH AMERICA CANCER DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 29 NORTH AMERICA GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 30 NORTH AMERICA GENETIC DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 31 NORTH AMERICA CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 32 NORTH AMERICA CARDIOVASCULAR DISEASE DIAGNOSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 33 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 34 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 35 NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 36 NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 37 USA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 38 USA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 39 USA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 40 USA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 41 USA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 42 USA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 43 USA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 44 USA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 45 CANADA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 46 CANADA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 47 CANADA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 48 CANADA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 49 CANADA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 50 CANADA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 51 CANADA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 52 CANADA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 53 MEXICO GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 54 MEXICO GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 55 MEXICO GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 56 MEXICO GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 57 MEXICO GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 58 MEXICO GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 59 MEXICO GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 60 MEXICO GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 61 REST OF NORTH AMERICA GENETIC TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 62 REST OF NORTH AMERICA GENETIC TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 63 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 64 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 65 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
  • TABLE 66 REST OF NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
  • TABLE 67 REST OF NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 68 REST OF NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 69 KEY INFORMATION - MYRIAD GENETICS, INC.
  • TABLE 70 KEY INFORMATION - EMPIRE GENOMICS LLC
  • TABLE 71 KEY INFORMATION - BIO-RAD LABORATORIES, INC.
  • TABLE 72 KEY INFORMATION - NOVARTIS AG
  • TABLE 73 KEY INFORMATION - AGILENT TECHNOLOGIES, INC.
  • TABLE 74 KEY INFORMATION - THERMO FISHER SCIENTIFIC, INC.
  • TABLE 75 KEY INFORMATION - QIAGEN N.V.
  • TABLE 76 KEY INFORMATION - ILLUMINA, INC.
  • TABLE 77 KEY INFORMATION - DANAHER CORPORATION
  • TABLE 78 KEY INFORMATION - ABBOTT LABORATORIES

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
Back to Top